SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 18.63 |
Enterprise Value ($M) | 45.72 |
Book Value ($M) | 7.53 |
Book Value / Share | 0.26 |
Price / Book | 2.48 |
NCAV ($M) | -43.19 |
NCAV / Share | -1.51 |
Price / NCAV | -0.43 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.53 |
Return on Assets (ROA) | -0.72 |
Return on Equity (ROE) | -2.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.37 |
Current Ratio | 0.48 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 36.23 |
Assets | 86.95 |
Liabilities | 79.42 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 8.68 |
Operating Income | -55.31 |
Net Income | -92.84 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -60.88 |
Cash from Investing | -0.87 |
Cash from Financing | 22.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Perceptive Advisors Llc | 4.40 | -8.66 | |
13D/A | Arch Venture Fund Vi Lp | |||
13G | Brii Biosciences Ltd | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
59,906 | 142,844 | 41.94 | |
36,740 | 128,119 | 28.68 | |
105,820 | 240,307 | 44.04 | |
20,574 | 9,132 | 225.30 | |
50,665 | 135,943 | 37.27 | |
(click for more detail) |
Similar Companies | |
---|---|
UNCY – Unicycive Therapeutics, Inc. | UPC – Universe Pharmaceuticals INC |
UPXI – Upexi, Inc. | VCNX – Vaccinex, Inc. |
VERU – Veru Inc. |
Financial data and stock pages provided by
Fintel.io